0

530313

KIMIABL

img img img img
No Data Available

KIMIA BIOSCIENCES LIMITED Share Price Update

As of the latest trading session, KIMIA BIOSCIENCES LIMITED share price is currently at ₹33.5, which is down by ₹-2.16 from its previous closing. Today, the stock has fluctuated between ₹33.00 and ₹37.00. Over the past year, KIMIA BIOSCIENCES LIMITED has achieved a return of -23.41%. In the last month alone, the return has been 15.62%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KIMIA BIOSCIENCES LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    158.50

  • P/E Ratio (TTM)

    20.61

  • Beta

    0.91

  • Book Value / share

    2.44

  • Return on equity

    172.53%

  • EPS (TTM)

    1.73

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    5.44

info icon alternate text

KIMIA BIOSCIENCES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 30.10
Operating Expense 25.15
Net Profit 5.44
Net Profit Margin (%) 18.07
Earnings Per Share (EPS) 1.15
EBITDA 6.64
Effective Tax Rate (%) -7.72
Particulars SEP 2025 (Values in Cr)
Revenue 34.00
Operating Expense 32.72
Net Profit 1.02
Net Profit Margin (%) 3.00
Earnings Per Share (EPS) 0.21
EBITDA 2.19
Effective Tax Rate (%) -7.36
Particulars JUN 2025 (Values in Cr)
Revenue 23.58
Operating Expense 23.74
Net Profit 0.60
Net Profit Margin (%) 2.54
Earnings Per Share (EPS) 0.13
EBITDA 3.38
Effective Tax Rate (%) 13.04
Particulars MAR 2025 (Values in Cr)
Revenue 38.24
Operating Expense 32.34
Net Profit 1.99
Net Profit Margin (%) 5.20
Earnings Per Share (EPS) 0.42
EBITDA 8.62
Effective Tax Rate (%) 68.61
Particulars DEC 2024 (Values in Cr)
Revenue 30.10
Operating Expense 26.93
Net Profit 4.57
Net Profit Margin (%) 15.18
Earnings Per Share (EPS) 0.97
EBITDA 5.43
Effective Tax Rate (%) -26.94
Particulars MAR 2025 (Values in Cr)
Revenue 118.92
Operating Expense 106.61
Net Profit 9.61
Net Profit Margin (%) 8.08
Earnings Per Share (EPS) 2.03
EBITDA 21.57
Effective Tax Rate (%) 29.49
Particulars MAR 2024 (Values in Cr)
Revenue 104.88
Operating Expense 113.70
Net Profit -5.31
Net Profit Margin (%) -5.06
Earnings Per Share (EPS) -1.12
EBITDA 1.16
Effective Tax Rate (%) 26.18
Particulars MAR 2023 (Values in Cr)
Revenue 128.52
Operating Expense 141.07
Net Profit -9.35
Net Profit Margin (%) -7.27
Earnings Per Share (EPS) -1.98
EBITDA -4.81
Effective Tax Rate (%) 24.53
Particulars MAR 2022 (Values in Cr)
Revenue 124.90
Operating Expense 130.85
Net Profit -3.70
Net Profit Margin (%) -2.96
Earnings Per Share (EPS) -0.78
EBITDA 1.56
Effective Tax Rate (%) 26.29
Particulars MAR 2021 (Values in Cr)
Revenue 132.71
Operating Expense 129.64
Net Profit 5.10
Net Profit Margin (%) 3.84
Earnings Per Share (EPS) 1.08
EBITDA 10.83
Effective Tax Rate (%) 7.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 2.11
ROE % 172.53
ROCE % 34.57
Total Debt to Total Equity 7.46
EBITDA Margin 18.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 16.69
EBITDA Margin 1.11
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 4.60
EBITDA Margin -3.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.15
ROE % -22.20
ROCE % -2.03
Total Debt to Total Equity 2.57
EBITDA Margin 1.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.90
ROE % 32.16
ROCE % 13.88
Total Debt to Total Equity 2.48
EBITDA Margin 8.17
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.68
Total Assets 111.21
Total Liabilities 111.21
Total Equity 9.96
Share Outstanding 4
Price to Book Ratio 20.15
Return on Assets (%) 8.64
Return on Capital (%) 22.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 99.96
Total Liabilities 99.96
Total Equity 0.33
Share Outstanding 4
Price to Book Ratio 796.14
Return on Assets (%) -5.31
Return on Capital (%) -12.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.49
Total Assets 121.31
Total Liabilities 121.31
Total Equity 5.46
Share Outstanding 4
Price to Book Ratio 28.26
Return on Assets (%) -7.70
Return on Capital (%) -16.02
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 109.49
Total Liabilities 109.49
Total Equity 14.88
Share Outstanding 4
Price to Book Ratio 11.94
Return on Assets (%) -3.38
Return on Capital (%) -6.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.67
Total Assets 106.66
Total Liabilities 106.66
Total Equity 18.43
Share Outstanding 4
Price to Book Ratio 9.73
Return on Assets (%) 4.78
Return on Capital (%) 8.06
Particulars MAR 2025 (Values in Cr)
Net Income 13.63
Cash from Operations 21.26
Cash from Investing -4.70
Cash from Financing -16.55
Net change in Cash 0.05
Free Cash Flow 25.86
Particulars MAR 2024 (Values in Cr)
Net Income -7.18
Cash from Operations 14.50
Cash from Investing -1.49
Cash from Financing -13.07
Net change in Cash -0.03
Free Cash Flow 16.01
Particulars MAR 2023 (Values in Cr)
Net Income -12.38
Cash from Operations -6.78
Cash from Investing -2.79
Cash from Financing 9.54
Net change in Cash -0.02
Free Cash Flow -3.97
Particulars MAR 2022 (Values in Cr)
Net Income -5.01
Cash from Operations 8.06
Cash from Investing -0.71
Cash from Financing -7.66
Net change in Cash -0.38
Free Cash Flow 11.64
Particulars MAR 2021 (Values in Cr)
Net Income 5.53
Cash from Operations 5.92
Cash from Investing -13.60
Cash from Financing 7.99
Net change in Cash 0.35
Free Cash Flow 19.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.49 11.90 1.42 210.66 23.12 / 46.00
BLISS GVS PHARMA LTD 229.90 21.98 2.14 2432.09 105.05 / 244.05
CIPLA LTD 1349.10 22.92 3.31 108977.69 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 327.30 10.89 2.46 963.28 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2584.40 43.53 25.63 43781.30 2220.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.49 26.43 3.83 210.66 23.12 / 46.00
AMRUTAJAN HEALTH LTD 628.00 31.40 5.30 1815.59 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8888.85 106.82 27.81 22222.13 6501.60 / 10653.05
BLISS GVS PHARMA LTD 229.90 31.32 2.20 2432.09 105.05 / 244.05

KIMIA BIOSCIENCES LIMITED shareholding pattern

Holding

24.67%
74.93%
0.38%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

KIMIA BIOSCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
33.50 -6.05 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 34.90
  • 26 Days 32.90
  • 10 Days 34.20
  • 50 Days 32.60
  • 12 Days 34.00
  • 100 Days 34.20
  • 20 Days 33.20
  • 200 Days 37.90
35.38 PIVOT

First Support

34.00

First Resistance

37.05

Second Support

32.33

Second Resistance

38.43

Third Support

30.95

Third Resistance

40.10

RSI

57.42

ADX

36.72

MACD

1.06

Williams % R

-55.38

Commodity Channel Index (CCI)

98.68

Date

2026-02-18

Week

27584.00

Same Day

10936.00

Month

11903.00

1 Year

0.91

3 Year

0.65

Over 1 Month

15.62%

down

Over 1 Year

-23.41%

down

Over 3 Months

6.54%

down

Over 3 Years

0.72%

down

Over 6 Months

-14.05%

down

Over 5 Years

-2.27%

down

KIMIA BIOSCIENCES LIMITED Corporate Actions

Top Gainers

KIMIA BIOSCIENCES LIMITED Share Price

Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The name of the Company was changed from 'Laurel Organics Limited' to 'Kimia Biosciences Limited' w.e..f 4 January, 2019. Since then, it engages in the business of Pharmaceutical products.

The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95.

During the 1998-99, the company has become a sick industrial units.

The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking. .The Hon'ble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Ho'ble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Hon'ble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview.

Pursuant to Scheme of Amalgamation as approved by NCLT vide its order dated August 21, 2018, the business of Kimia Biosciences Limited, which was engaged in the business of Sale & Manufacturing of Bulk Drugs (API)), was merged with the business of the Company as going concern, making the Scheme effective from September 17, 2018. The merger involved the consolidation of 37,28,100 equity shares held by Kimia Biosciences Limited.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kimia Biosciences Ltd?

Answer Field

Kimia Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 33.50 as on Feb 19 2026 03:29 PM.

What is the Market Cap of Kimia Biosciences Ltd Share?

Answer Field

The market cap of Kimia Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 158.50 as on Feb 19 2026 03:29 PM.

What is the 52 Week High and Low of Kimia Biosciences Ltd?

Answer Field

The 52 Week High and Low of Kimia Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 86.85 and ₹ 26.09.

What is 1 year return for Kimia Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been -23.41%.

What is the P/E Ratio of Kimia Biosciences Ltd Share?

Answer Field

As on Feb 19 2026 03:29 PM the price-to-earnings (PE) ratio for Kimia Biosciences Ltd share is 20.61.

What is the PB ratio of Kimia Biosciences Ltd Share?

Answer Field

As on Feb 19 2026 03:29 PM, the price-to-book (PB) ratio for Kimia Biosciences Ltd share is 2.44.

How to Buy Kimia Biosciences Ltd Share?

Answer Field

You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kimia Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Kimia Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kimia Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59